New oral eczema drug shows promise in Mid-Stage trial

NCT ID NCT07217015

Recruiting now Disease control Sponsor: Kymera Therapeutics, Inc. Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 23 times

Summary

This study tests an oral medication called KT-621 for people aged 12 to 75 with moderate-to-severe atopic dermatitis (eczema). The goal is to see if it safely reduces skin redness, itching, and affected body area compared to a placebo. The trial lasts 16 weeks with a follow-up period of up to 52 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Kymera Investigative Site
RECRUITING

Birmingham, Alabama, 35244, United States
Kymera Investigative Site
RECRUITING

North Little Rock, Arkansas, 72117, United States
Kymera Investigative Site
RECRUITING

Freemont, California, 94538, United States
Kymera Investigative Site
RECRUITING

Los Angeles, California, 90025, United States
Kymera Investigative Site
RECRUITING

Los Angeles, California, 90045, United States
Kymera Investigative Site
RECRUITING

Santa Monica, California, 91350, United States
Kymera Investigative Site
RECRUITING

Delray Beach, Florida, 33484, United States
Kymera Investigative Site
RECRUITING

Miami, Florida, 33137, United States
Kymera Investigative Site
RECRUITING

Miramar, Florida, 33027, United States
Kymera Investigative Site
RECRUITING

Normal, Illinois, 61761, United States
Kymera Investigative Site
RECRUITING

Indianapolis, Indiana, 46202, United States
Kymera Investigative Site
RECRUITING

Ann Arbor, Michigan, 48103, United States
Kymera Investigative Site
RECRUITING

Detroit, Michigan, 48202, United States
Kymera Investigative Site
RECRUITING

The Bronx, New York, 10455, United States
Kymera Investigative Site
RECRUITING

Fargo, North Dakota, 58103, United States
Kymera Investigative Site
RECRUITING

Portland, Oregon, 97201, United States
Kymera Investigative Site
RECRUITING

Portland, Oregon, 97239, United States
Kymera Investigative Site
RECRUITING

Philadelphia, Pennsylvania, 19103, United States
Kymera Investigative Site
RECRUITING

San Antonio, Texas, 78213, United States
Kymera Investigative Site
RECRUITING

San Antonio, Texas, 78218, United States
Kymera Investigative Site
RECRUITING

Darlinghurst, New South Wales, Australia
Kymera Investigative Site
RECRUITING

Kogarah, New South Wales, Australia
Kymera Investigative Site
RECRUITING

Brisbane, Queensland, Australia
Kymera Investigative Site
RECRUITING

Woolloongabba, Queensland, Australia
Kymera Investigative Site
RECRUITING

Melbourne, Victoria, Australia
Kymera Investigative Site
RECRUITING

Calgary, Alberta, Canada
Kymera Investigative Site
RECRUITING

Edmonton, Alberta, Canada
Kymera Investigative Site
RECRUITING

Kelowna, British Columbia, Canada
Kymera Investigative Site
RECRUITING

Surrey, British Columbia, Canada
Kymera Investigative Site
RECRUITING

Markham, Ontario, Canada
Kymera Investigative Site
RECRUITING

Ottawa, Ontario, Canada
Kymera Investigative Site
RECRUITING

Richmond Hill, Ontario, Canada
Kymera Investigative Site
RECRUITING

Toronto, Ontario, Canada
Kymera Investigative Site
RECRUITING

Québec, Quebec, Canada
Kymera Investigative Site
RECRUITING

Pardubice, Czechia
Kymera Investigative Site
RECRUITING

Prague, Czechia
Kymera Investigative Site
RECRUITING

Augsburg, Bavaria, Germany
Kymera Investigative Site
RECRUITING

München, Bavaria, Germany
Kymera Investigative Site
RECRUITING

Bad Bentheim, Germany
Kymera Investigative Site
RECRUITING

Berlin, Germany
Kymera Investigative Site
RECRUITING

Dresden, Germany
Kymera Investigative Site
RECRUITING

Mainz, Germany
Kymera Investigative Site
RECRUITING

Ichikawa, Chiba, Japan
Kymera Investigative Site
RECRUITING

Kagoshima, Japan
Kymera Investigative Site
RECRUITING

Kanagawa, Japan
Kymera Investigative Site
RECRUITING

Osaka, Japan
Kymera Investigative Site
RECRUITING

Sakai, Japan
Kymera Investigative Site
RECRUITING

Chorzów, Poland
Kymera Investigative Site
RECRUITING

Gdansk, Poland
Kymera Investigative Site
RECRUITING

Gdynia, Poland
Kymera Investigative Site
RECRUITING

Krakow, Poland
Kymera Investigative Site
RECRUITING

Lublin, Poland
Kymera Investigative Site
RECRUITING

Rzeszów, Poland
Kymera Investigative Site
RECRUITING

Szczecin, Poland
Kymera Investigative Site
RECRUITING

Warsaw, Poland
Kymera Investigative Site
RECRUITING

Wroclaw, Poland
Kymera Investigative Site
RECRUITING

Ansan-si, South Korea
Kymera Investigative Site
RECRUITING

Cheonan, South Korea
Kymera Investigative Site
RECRUITING

Gyeonggi-do, South Korea
Kymera Investigative Site
RECRUITING

Incheon, South Korea
Kymera Investigative Site
RECRUITING

Seoul, South Korea

Conditions

Explore the condition pages connected to this study.

ATOPIC DERMATITIS